Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence;Actividad de la telomerasa y longitud del telómero en la secuencia pólipo-carcinoma colorrectal

Revista Espanola de Enfermedades Digestivas

Volumn 101, Issue 3, 2009, Pages 179-186

  Valls Bautista, C ^a   Piñol Felis, Carme ^a   Rene Espinet J M ^a,b   Buenestado Garcia J ^a,b   Vinas Salas J ^a,b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Carcinoma; Colorectal; Polyp; Telomerase activity; Telomere length

Indexed keywords

TELOMERASE;

ARTICLE; CANCER PATIENT; CANCER TISSUE; CHROMOSOME SIZE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; RECTUM MUCOSA; RECTUM POLYP; SOUTHERN BLOTTING; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; COLON POLYP; COLORECTAL TUMOR; DISEASE COURSE; ENZYMOLOGY; GENETICS; METABOLISM; PILOT STUDY;

COLONIC POLYPS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; PILOT PROJECTS; TELOMERASE; TELOMERE;

EID: 67650596836     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082009000300004     Document Type: Article

References (24)

1. Ponz de Leon M, Di Gregorio C. Pathology of colorectal cancer. Dig Liver Dis 2001; 33(4): 372-388
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5): 759-767
3. Cruz-Bustillo Clarens D. Génetica molecular del cáncer colorectal. Rev Esp Enferm Dig 2004; 96(1): 48-59.
4. Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003; 9(12): 2642-2649 (Pubitemid 38054431)
5. Benito M, Díaz-Rubio E. Molecular biology in colorectal cancer. Clin Trans Oncol 2006; 8(6): 391-398
6. Fenoglio-Preiser CM, Noffsinger A. Aberrant crypt foci: A review. Toxicol Pathol 1999; 27(6): 632-642
7. Blackburn EH. Structure and function of telomeres. Nature 1991; 350(6319): 569-573
8. Shay JW, Zou Y, Hiyama E, Wright WE. Telomerase and cancer. Hum Mol Genet 2001; 310(7): 677-685
9. Hiyama E, Hiyama K. Telomerase as tumor marker. Cancer Lett 2003; 194(2): 221-233
10. Bautista CV, Felis CP, Espinet JM, Salas J. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer. Dis Colon Rectum 2007; 50(5): 611-620 (Pubitemid 46870465)
11. Saleh S, Lam AK, Ho YH. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology 2008; 40: 25-30. (Pubitemid 350172947)
12. Kammori M, Kanauchi H, Nakamura K, Kawahara M, Weber TK, Mafune KI, et al. Demonstration of human telomerase reverse transcriptase in human colorectal carcinoma by in situ hybridization. Int J Oncol 2002; 20(1): 15-21.
13. Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, et al. Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med 2002; 10(5): 589-592
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266(5193): 2011-2015
15. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995; 17: 1-15.
16. Katayama S, Shiota G, Oshimura M, Kawasaki H. Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer. J Cancer Res Clin Oncol 1999; 125(7): 405-410 (Pubitemid 29287499)
17. Abe N, Watanabe T, Nakashima M, Masaki T, Mori T, Sugiyama M, et al. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal cancer. Hepatogastroenterology 2001; 48(39): 692-695 (Pubitemid 32619662)
18. Yan P, Saraga EP, Bouzourene H, Bosman FT, Benhattar J. Telomerase activation in colorectal carcinogenesis. J Pathol 1999; 189(2): 207-212
19. Tang R, Cheng AJ, Wang JY, Wang TC. Close correlation between telomerase expression and adematous polyp progression in multistep colorectal carcinogenesis. Cancer Res 1998; 58(18): 4052-4054 (Pubitemid 28440553)
20. Engelhardt M, Drullinsky P, Guillem J. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997; 122(11): 1141-1145 (Pubitemid 27505118)
21. Mizumoto I, Ogawa Y, Niiyama H, Nagai E, Sato I, Urashima T, et al. Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis. Am J Gastroenterol 2001; 96(4): 1261-1265 (Pubitemid 32327943)
22. Bechter OE, Zou Y, Walter W, Wright WE, Shay JW. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res 2004; 64(10): 3444-3451 (Pubitemid 38657916)
23. Nittis T, Guittat L, Stewart SA. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection? Biochimie 2008; 90(1): 5-12.
24. Kim HR, Kim YJ, Kim HJ, Kim SK, Lee JH. Telomere length changes in colorectal cancers and polyps. J Korean Med Sci 2002; 17(3): 360-365